Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients.
CONCLUSION: RYGB, but not SG, promotes a significant reduction in plasma PCSK9 levels, and such changes in circulating PCSK9 levels after RYGB appear to be more associated with glucose improvement than with lipid homoeostasis parameters.
PMID: 32032671 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Blanchard C, Ledoux S, Verhaegen A, Wargny M, Letessier E, Stepanian A, Huten N, Jacobi D, Krempf M, Bras ML, Guillouche MP, Arnaud L, Pichelin M, Gaal LV, Cariou B, May CL Tags: Diabetes Metab Source Type: research
More News: Bariatric Surgery | Belgium Health | Cholesterol | Diabetes | Eating Disorders & Weight Management | Endocrinology | France Health | Gastrectomy | Gastric Bypass | Gastroenterology | Obesity | Study | Weight Loss